Latest Breaking News On - Xiaoping luo - Page 1 : vimarsana.com

SHANGHAI and GAITHERSBURG, Md., May 31, 2022 /PRNewswire/ I-Mab , a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics,. | May 31, 2022

United statesHong kongSan diegoEmilie wuXiaoping luoJun liuAndrew zhuGigi fengRichard yehJumpcan pharmaceutical groupPrnewswire the company nasdaqPiacente group incExchange commissionDepartment of pediatrics at wuhan tongji hospitalProfessor xiaoping luoWuhan tongji